Uzm. Dr. Taliha Güçlü Kantar

Real-world outcomes of second-line therapy in advanced thymic carcinoma: a multicenter Turkish Oncology Group (TOG) study

BMC Cancer, 2026

DOI 10.1186/s12885-026-16868-5 Texte intégral en libre accèsSource : OpenAlex

Prognostic Value of Systemic Inflammatory Markers in Locally Advanced or Metastatic Melanoma: A Real-World Analysis

Cancers, 2026

DOI 10.3390/cancers18030420 PMID 41681891 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Differential Metastatic Patterns and Prognostic Value of Systemic Inflammation Scores in Anaplastic Lymphoma Kinase Rearranged Versus Anaplastic Lymphoma Kinase Negative Non-Small Cell Lung Cancer

Cancers, 2026

DOI 10.3390/cancers18030501 PMID 41681973 2 citations (Europe PMC) Texte intégral en libre accèsSource : OpenAlex

Meme Kanseri

Akademisyen Kitabevi eBooks, 2026

DOI 10.37609/akya.3852 Texte intégral en libre accèsSource : OpenAlex

Role of Prognostic Nutritional Index and C-Reactive Protein/Albumin Ratio in Prognosis of Locally Advanced Nasopharyngeal Carcinoma

Medicina, 2026

DOI 10.3390/medicina62020377 PMID 41752776 Texte intégral en libre accèsSource : OpenAlex

Inflammation-tumor burden interaction score stratifies survival after irinotecan-eluting bead chemoembolization for colorectal liver metastases

Frontiers in Medicine, 2026

DOI 10.3389/fmed.2026.1751660 PMID 41907246 Texte intégral en libre accèsSource : OpenAlex

Prevalence and Prognostic Significance of Positron Emission Tomography–Computed Tomography–Defined Low Skeletal Muscle Mass (Radiological Sarcopenia) in Metastatic Breast Cancer

Cerrahpaşa Medical Journal, 2026

DOI 10.5152/cjm.2026.26112 Texte intégral en libre accèsSource : ORCID

Skeletal Muscle Index and Baseline Biomarkers in Atezolizumab-Treated Extensive-Stage Small-Cell Lung Cancer: A Real-World Cohort Study

Current Oncology, 2026

DOI 10.3390/curroncol33100639 PMID 42930206 Texte intégral en libre accèsSource : ORCID

Prognostic Role of Inflammatory Indices and Real-World Outcomes in HER2-Positive Metastatic Breast Cancer Treated with Trastuzumab Emtansine

Diagnostics, 2026

DOI 10.3390/diagnostics16111746 PMID 42279613 Texte intégral en libre accèsSource : ORCID

The Royal Marsden Hospital Score Independently Predicts Overall Survival in Patients with De Novo Metastatic Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitors: A Multicenter Retrospective Analysis

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15103613 PMID 42194578 Texte intégral en libre accèsSource : ORCID

Association of Increased Cardio-Ankle Vascular Index (CAVI) with Echocardiographically Impaired Diastolic Dysfunction and Low Klotho Levels in Kidney Transplant Patients

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15072727 PMID 41977028 Texte intégral en libre accèsSource : ORCID

On-treatment dNLR and metastatic burden predict survival in advanced non-small-cell lung cancer treated with nivolumab

Turkish Journal of Clinics and Laboratory, 2026

DOI 10.18663/tjcl.1849630 Texte intégral en libre accèsSource : ORCID

Second Primary Malignancies After Appendiceal Neuroendocrine Tumors: A Contemporary SEER-Based Standardized Incidence Ratio Analysis (2015-2023)

Asian Pacific journal of cancer prevention : APJCP, 2026

DOI 10.31557/apjcp.2026.27.10.3857 PMID 42935079 Source : Europe PMC

Integration of Ki67 and Pan-Immune-Inflammation Value (PIV) into a predictive nomogram for pathologic complete response in triple-negative breast cancer

BMC Cancer, 2026

DOI 10.1186/s12885-026-15842-5 PMID 41814226 1 citation (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017–2025)

Cancer Investigation, 2026

DOI 10.1080/07357907.2025.2611945 PMID 41527482 Source : OpenAlex

Proliferation-Guided Risk Stratification in HER2-Low versus HER2-Positive Hormone Receptor-Positive Breast Cancer: A Multicenter Retrospective Analysis

Oncology Research and Treatment, 2026

DOI 10.1159/000550484 PMID 41528926 Source : OpenAlex

Temporal Trends in Clinicopathological Features and Outcomes of De Novo Metastatic Luminal A Breast Cancer: A Retrospective Multicenter Analysis (2017–2025)

Figshare, 2026

DOI 10.6084/m9.figshare.31055498 Texte intégral en libre accèsSource : OpenAlex

Meme Kanseri Epidemiyolojisi ve Risk Sınıflaması

Akademisyen Kitabevi eBooks, 2026

DOI 10.37609/akya.3852.c2749 Source : OpenAlex

Real-World Outcomes and Prognostic Factors in Patients with Radioiodine-Refractory Differentiated Thyroid Cancer Treated with Sorafenib: A Multicenter Study

Journal of Clinical Medicine, 2026

DOI 10.3390/jcm15134880 PMID 42452343 Texte intégral en libre accèsSource : OpenAlex

Development of a Composite Risk Score and Real-world Outcomes in Advanced Pancreatic Adenocarcinoma: Prognostic Value of Baseline 18F-FDG PET/CT Metabolic Parameters

Acta haematologica oncologica Turcica., 2026

DOI 10.4274/ahot.galenos.2026.2026-7-3 Texte intégral en libre accèsSource : OpenAlex

Clinical Predictors of Progression-free Survival in Patients with Metastatic Castration-resistant Prostate Cancer Treated with Lu-177 PSMA: A Real-world Study

Journal of Oncological Sciences, 2026

DOI 10.37047/jos.galenos.2026.2026-7-11 Texte intégral en libre accèsSource : OpenAlex

Real‐world effectiveness and safety of sacituzumab govitecan in patients with metastatic or unresectable locally advanced triple‐negative breast cancer: A multicenter study by the Turkish Oncology Group

International Journal of Cancer, 2025

DOI 10.1002/ijc.70213 PMID 41147655 3 citations (Europe PMC) Source : OpenAlex

Prognostic Value of a New Marker, IBI Score and NLR Change in Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors (Prognostic value of IBI score and NLR change in NSCLC)

Muğla Sıtkı Koçman Üniversitesi Tıp Dergisi, 2025

DOI 10.47572/muskutd.1603917 Texte intégral en libre accèsSource : OpenAlex

The impact of SARS-CoV-2 infection on the survival in NSCLC patients undergoing immunotherapy

Pamukkale Medical Journal, 2025

DOI 10.31362/patd.1598359 Texte intégral en libre accèsSource : OpenAlex

Real-World Outcomes of Treatment Approaches and the Impact of Systemic Inflammation Markers on Survival in Patients with Locally Advanced and Metastatic Laryngeal Cancer

Journal of Clinical Medicine, 2025

DOI 10.3390/jcm14248924 PMID 41464825 Texte intégral en libre accèsSource : OpenAlex

Prognostic Role of Inflammatory and Nutritional Indices in NSCLC Patients Treated with Immune Checkpoint Inhibitors: Retrospective, Multicenter, Turkish Oncology Group Study of Overall and Elderly Populations

Medicina, 2025

DOI 10.3390/medicina61071160 PMID 40731790 7 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Neoadjuvant Regimens and Their Impact on Adjuvant T-DM1 Outcomes in HER2-Positive Early Breast Cancer

Medicina, 2025

DOI 10.3390/medicina61111966 PMID 41303803 2 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Medical oncologists’ dance with international guidelines and national reimbursement: insights from a survey in Türkiye

Expert Review of Pharmacoeconomics & Outcomes Research, 2025

DOI 10.1080/14737167.2025.2462238 PMID 39899025 Source : OpenAlex

3005P Radioiodine-refractory differentiated thyroid cancer (RAI-R DTC) patients treated with sorafenib monotherapy: Real-world treatment patterns and clinical outcomes in Türkiye

Annals of Oncology, 2025

DOI 10.1016/j.annonc.2025.08.3619 Texte intégral en libre accèsSource : OpenAlex

Prognostic Value of ALBI Score and Lymphocyte-Associated Inflammation Markers in Advanced Hepatocellular Carcinoma: A Single Centre Retrospective Cross-Sectional Study

Namık Kemal Tıp Dergisi, 2024

DOI 10.4274/nkmj.galenos.2024.93898 3 citations (OpenAlex) Texte intégral en libre accèsSource : OpenAlex

Use of albumin and CRP related immuno-nutritional markers for prediction of locoregional response to treatment in unresectable hepatocellular carcinoma

Pamukkale Medical Journal, 2024

DOI 10.31362/patd.1471860 Texte intégral en libre accèsSource : OpenAlex

THE EFFECT OF PRE-TREATMENT INFLAMMATORY RESPONSE MARKERS ON SURVIVAL IN LOCALLY ADVANCED UNRESECTABLE AND METASTATIC GASTRIC CANCER: A RETROSPECTIVE CROSS-SECTIONAL STUDY

Pamukkale Medical Journal, 2023

DOI 10.31362/patd.1265291 Texte intégral en libre accèsSource : OpenAlex

PROGNOSTIC SIGNIFICANCE OF SYSTEMIC IMMUNE INFLAMMATION INDICES AND PROGNOSTIC NUTRITIONAL INDEX BEFORE CDK4/6 INHIBITOR THERAPY IN HORMONE RECEPTOR POSITIVE, HER2 NEGATIVE METASTATIC BREAST CANCER PATIENTS

Pamukkale Medical Journal, 2023

DOI 10.31362/patd.1268419 Texte intégral en libre accèsSource : OpenAlex